ATE143692T1 - Neuer impfstoff - Google Patents

Neuer impfstoff

Info

Publication number
ATE143692T1
ATE143692T1 AT90917062T AT90917062T ATE143692T1 AT E143692 T1 ATE143692 T1 AT E143692T1 AT 90917062 T AT90917062 T AT 90917062T AT 90917062 T AT90917062 T AT 90917062T AT E143692 T1 ATE143692 T1 AT E143692T1
Authority
AT
Austria
Prior art keywords
new vaccine
vaccine
toxin
deficient
express
Prior art date
Application number
AT90917062T
Other languages
English (en)
Inventor
Camille Locht
Yves Lobet
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Application granted granted Critical
Publication of ATE143692T1 publication Critical patent/ATE143692T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90917062T 1989-11-29 1990-11-26 Neuer impfstoff ATE143692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44280889A 1989-11-29 1989-11-29
US45564889A 1989-12-22 1989-12-22

Publications (1)

Publication Number Publication Date
ATE143692T1 true ATE143692T1 (de) 1996-10-15

Family

ID=27033297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90917062T ATE143692T1 (de) 1989-11-29 1990-11-26 Neuer impfstoff

Country Status (12)

Country Link
EP (1) EP0502016B1 (de)
JP (1) JPH05503628A (de)
KR (1) KR920703098A (de)
AT (1) ATE143692T1 (de)
AU (1) AU644828B2 (de)
CA (1) CA2069622A1 (de)
DE (1) DE69028785T2 (de)
HK (1) HK1004569A1 (de)
IE (1) IE904274A1 (de)
NZ (1) NZ236230A (de)
PT (1) PT96022B (de)
WO (1) WO1991008294A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0666758B1 (de) 1992-10-02 2001-12-12 Alberta Research Council Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
EP1489092A1 (de) * 2003-06-18 2004-12-22 Institut Pasteur Modifizierte Bordetella Adenylatcyclase mit oder ohne CD11b/CD18 Interaktionsdomäne und seine Verwendungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine

Also Published As

Publication number Publication date
WO1991008294A1 (en) 1991-06-13
JPH05503628A (ja) 1993-06-17
AU6736390A (en) 1991-06-26
IE904274A1 (en) 1991-06-05
PT96022B (pt) 1997-01-31
EP0502016B1 (de) 1996-10-02
AU644828B2 (en) 1993-12-23
KR920703098A (ko) 1992-12-17
PT96022A (pt) 1991-09-30
DE69028785D1 (de) 1996-11-07
DE69028785T2 (de) 1997-03-27
EP0502016A1 (de) 1992-09-09
NZ236230A (en) 1992-09-25
HK1004569A1 (en) 1998-11-27
CA2069622A1 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
DK0606317T3 (da) Saponin-antigen-konjugater og anvendelsen deraf
NO2006005I2 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
GB9713156D0 (en) Vaccines
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
DK208985D0 (da) Antigent praeparat og fremgangsmaade til isolering af et saadantpraeparat
NO833685L (no) Inndrivningsapparat for spiker og liknende festeelementer
IT1179444B (it) Composizione farmaceutica a base di estratto solubile in piridina e di endotossina detossicata raffinata e suo impiego
DE69028785D1 (de) Neuer impfstoff
DK218886D0 (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
DK355789D0 (da) Bordetella pertussis vaccine
NO983220D0 (no) Sammensetninger og fremgangsmater for ö administrere Borrelia Burgdorferi-antigener
KR930703006A (ko) 백신, 특히 돼지의 흉막폐염 백신의 면역강화
DE69128095D1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties